| 中文名称 | 那法瑞林 |
|---|---|
| 中文别名 | 萘法瑞林;那法瑞林;醋酸那法瑞林;醋酸那法瑞林 Nafarelin Acetate;醋酸那法瑞林 ?Nafarelin?Acetate;醋酸那法瑞林 NafarelinAcetate;6-[3-(2-萘)-D-丙氨酸]促黄体激素刺激因子;萘法林 |
| 英文名称 | Nafarelin |
| 英文别名 | Nafarelin;(D-2-Nal?)-LHRH;(D-2-Nal⁶)-LHRH;Nafarelin Acetate;Nacenyl;NAF;Nafareline;Nasanyl;Synarel;Synrelina;Luteinizinghormone-releasing factor (pig), 6-[3-(2-naphthalenyl)-D-alanine]-;NAG;[6-D-(2-naphthyl)-alanine]LH-RH;26: PN:WO2007012430 SEQID: 28 claimed protein;Nafarelinum;Nafarelina;Nafarelinum [Latin];Nafareline [French];Nafarelina [Spanish];Nafarelin [INN:BAN];1X0094V6JV;LHRH, Ala(2-naphthyl)(6)-;6-(3-(2-Naphthalenyl)-D-alanine)luteinizing hormone-releasing factor (pig);C66H83N17O13;BIDD:GT0760;BDBM84707;Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-;DB00666;K335;932N564;Luteinizing hormo;C76463;76932-56-4;6-D-(2-naphthyl)alanyl-GnRH;(2S)-N-(2-amino-2-oxoethyl)-1-((2S,5S,8R,11S,14S,17S,20S)-2-(3-carbamimidamidopropyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-20-(1H-imidazol-4-ylmethyl)-17-(1H-indol-3-ylmethyl)-5-(2-methylpropyl)-8-(naphthalen-2-ylmethyl)-4,7,10,13,16,19,22-heptaoxo-22-((2S)-5-oxopyrrolidin-2-yl)-3,6,9,12,15,18,21-heptaazadocosan-1-oyl)pyrrolidine-2-carboxamide;DTXSID001031284;NAFARELIN [VANDF];Q3869873;H01CA02;NAFARELIN [MI];AKOS015895038;UNII-1X0094V6JV;GTPL3902;Nafarelinum (Latin);SCHEMBL22518;(6-D-(2-naphthyl)alanine)-GnRH;5-oxo-L-prolyl L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide;CHEBI:7445;NAFARELIN [INN];5-OXOPRO-HIS-TRP-SER-TYR-D-NAL(2)-LEU-ARG-PRO-GLY-NH2;NAFARELIN [WHO-DD];HS-2018;(S)-1-(((R)-2-((S)-2-((S)-2-((S)-2-((S)-3-(1H-imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(naphthalen-2-yl)propanoyl)-L-leucyl-L-arginyl)-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide;(S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-15-(naphthalen-2-ylmethyl)-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide;CCG-270673;L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolyl-glycinamide;EN300-7480908;NS00078790;Nafarelin? |
| CAS No. | 76932-56-4 |
| 分子式 | C66H83N17O13 |
| 分子量 | 1322.47 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学